Enveric Biosciences, Inc. Stock Price

NasdaqCM:ENVB Community·US$3.7m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
3 Fair Values set on narratives written by author

Create a narrative

ENVB Share Price Performance

US$5.70

-78.94 (-93.27%)

US$5.70

-78.94 (-93.27%)

US$5.70

Wed, 5 Nov 25

Share PriceUS$5.70

ENVB Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

Moderate risk with adequate balance sheet.

5 Risks

1 Reward

View Full Analysis

Enveric Biosciences, Inc. Key Details

Last Reported Earnings

Jun 30, 2025

Next Reporting Earnings

n/a

: -19.18
: 0%
: 0%
: 4.6%

View Full Analysis

About ENVB

Founded: n/a
Employees: 6
CEO: Joseph Tucker
WebsiteView website: www.enveric.com

Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. The company offers product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. It also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer. The company is headquartered in Cambridge, Massachusetts.